Relapse rates after detox and rehabilitation remain a significant challenge in the treatment of substance use disorder (SUD). Studies show that between 40% and...
In a surprising and strategic move, FOXO Technologies (NYSE American: FOXO), a biotech company known for its advancements in epigenetics and AI-driven health solutions,...
A bipartisan group of five U.S. senators recently announced a significant legislative effort aimed at improving addiction treatment in prisons. The bill, called the...
Traditional addiction treatment models often require individuals to leave their homes, jobs, and families to receive care in a facility-based setting. While this approach...